Febrile Seizure

• Temperature-dependent alterations in neuronal excitability: Elevated body temperature increases metabolic rate and alters the balance between excitatory and inhibitory neurotransmission. The immature brain has a lower seizure threshold, partly due to incomplete myelination, reduced GABAergic inhibition, and higher density of glutamatergic receptors. The critical temperature threshold varies by individual genetic makeup rather than absolute fever height.

• Developmental immaturity of inhibitory networks: The pediatric brain demonstrates reduced expression of GABA-A receptors and delayed maturation of inhibitory circuits. Immature potassium channels fail to effectively limit repetitive firing, while developmental delays in myelin formation impair rapid signal propagation necessary for seizure termination. These features explain the age-limited nature of febrile seizures.

• Genetic susceptibility mechanisms: Twin studies demonstrate 40% concordance, indicating significant heritable components. Mutations in sodium channel genes (SCN1A, SCN1B), GABA-A receptor subunits (GABRG2), and potassium channel genes have been identified. Polymorphisms affecting inflammatory cytokines (IL-1β, TNF-α) may enhance fever-induced CNS inflammation. Genomic variants determine individual seizure threshold and fever sensitivity.

• Inflammatory cascade activation: Elevated temperatures trigger release of pyrogenic cytokines (IL-1, IL-6, TNF-α) from peripheral immune cells and activated glial cells. These cytokines increase prostaglandin E2 production and act on hypothalamic TRPV1 receptors to reset the temperature set-point. Concurrent enhancement of glutamate release and reduction in GABA synthesis lower seizure threshold during fever.

Age and developmental factors

• Optimal window: 6 months to 5 years (peak 18-24 months)
• Brain developmental stage and threshold setting determine seizure susceptibility
• Rare before 6 months or after 6 years of age

Febrile illness triggers

• Viral infections (most common): respiratory syncytial virus (RSV), influenza, parainfluenza, human herpesvirus-6 (HHV-6), adenovirus, rotavirus
• Bacterial infections: otitis media, pneumonia, urinary tract infection (typically without bacteremia)
• Vaccinations: live attenuated vaccines (MMR, varicella) can trigger fever-related seizures 1-2 weeks post-administration
• Fever from any source at sufficient height and rate of rise

Genetic predisposition

• Positive family history: 25-40% of children with febrile seizures have affected first-degree relatives
• Autosomal dominant inheritance with incomplete penetrance in some families
• Specific genetic syndromes: generalized epilepsy and febrile seizures plus (GEFS+) associated with SCN1A mutations

Constitutional factors

• Prematurity and developmental delay increase risk
• Higher seizure threshold in African and Mediterranean ancestry; lower in Asian ancestry
• Male preponderance (slightly, approximately 1.2:1)

Fever characteristics

• Rapid rate of temperature rise more predictive than absolute temperature
• First febrile illness carries higher risk than subsequent episodes
• Seizures often occur during defervescence phase

Cardinal features of simple febrile seizures

• Generalized tonic-clonic seizure activity lasting 10-15 seconds to 2 minutes (by definition <15 minutes)
• Occurs during active febrile illness with fever ≥38.5°C (101.3°F) rectal temperature
• Single seizure per febrile episode
• Postictal confusion or lethargy lasting minutes to brief period
• No focal neurologic signs or lateralization

Complex febrile seizures demonstrate

• Prolonged duration (≥15 minutes), creating risk for febrile status epilepticus
• Focal seizure activity with unilateral motor signs or focal phase followed by generalization
• Multiple seizures (2 or more) within 24-hour period
• Postictal paresis (Todd's paralysis) lasting minutes to hours

Associated symptoms during event

• Fever with chills, diaphoresis from underlying infection
• Eye deviation, nystagmus during convulsive phase
• Incontinence during generalized seizure
• Tongue biting (though less common than in primary epilepsy)
• Apnea during tonic phase with cyanosis possible

Physical examination findings

• Elevated core body temperature (typically 39-40°C or higher)
• Signs of acute infection: pharyngitis, otitis media, upper respiratory congestion, rash (evaluate for meningococcemia or enteroviral exanthem)
• Post-ictal somnolence and confusion, gradually clearing
• Transient focal neurologic deficits (Todd's paresis) in complex cases, resolving completely
• Absence of meningeal signs (nuchal rigidity, Kernig's/Brudzinski's signs)—if present, meningitis must be excluded

Clinical diagnostic criteria

• Simple febrile seizure definition: Age 6 months to 5 years, seizure duration <15 minutes, single episode per fever illness, generalized onset without focal features, normal baseline development, no CNS infection
• Complex febrile seizure definition: Duration ≥15 minutes OR focal features OR multiple seizures in 24 hours, occurring in same age range

Evaluation mandatory components

• Assess for CNS infection: Clinical examination for meningeal signs (nuchal rigidity, Kernig's sign, Brudzinski's sign). Lumbar puncture indicated if: (1) first simple febrile seizure in child <12 months (due to atypical meningitis presentation), (2) inadequate treatment of bacterial meningitis, (3) immunodeficiency, (4) difficult examination, (5) any clinical suspicion for meningitis despite age. Consider LP for first complex seizure under age 12 months.

• Blood work: CBC reveals leukocytosis typical of viral infection (WBC 10,000-20,000). Blood culture if bacteremia suspected from presentation. Electrolytes generally normal; check if seizure complicated or refractory. Glucose and calcium occasionally checked if seizure atypical.

• Cerebrospinal fluid analysis (if obtained): Should show pleocytosis <100 cells with lymphocytic predominance in viral infection (though early viral meningitis shows neutrophilic predominance). Glucose >40 mg/dL and normal protein (typically <100 mg/dL). Negative bacterial culture and normal Gram stain.

• Electroencephalography (EEG): NOT routinely indicated for simple febrile seizures—background activity returns to normal when fever resolves. May show generalized slowing during acute fever without epileptiform abnormalities. Consider EEG for: (1) complex febrile seizures, (2) status epilepticus, (3) atypical presentation, (4) recurrent episodes. Presence of interictal spike activity does not change management.

• Neuroimaging (CT/MRI): NOT routinely indicated for simple febrile seizures with normal neurologic exam. MRI reserved for: (1) focal neurologic deficits persisting beyond 1 hour, (2) asymmetric seizure features, (3) abnormal baseline development, (4) recurrent complex seizures suggesting underlying structural lesion.

• Exclude other diagnoses: Metabolic seizures (hypoglycemia, hypocalcemia, hyponatremia), drug toxicity, and abusive head trauma must be considered in context.

Acute management during active febrile seizure

• Benzodiazepines for seizure termination: Lorazepam 0.1 mg/kg IV (preferred) or diazepam 0.5 mg/kg IV/IM ends most seizures within 2-5 minutes. Midazolam 0.2 mg/kg IM or intranasal effective when IV access unavailable. If seizure continues beyond 5 minutes, second dose of benzodiazepine or transition to second-line agent.

• Second-line seizure termination: Phenytoin 15-20 mg/kg IV infused slowly (max 50 mg/min) for seizures lasting >15 minutes unresponsive to benzodiazepines. Fosphenytoin preferred due to better tolerability. Levetiracetam 20-30 mg/kg IV increasingly used as alternative. Supportive care with oxygen, airway positioning, continuous monitoring.

• Fever management: Expedited antipyretic use (acetaminophen 15 mg/kg PO or ibuprofen 10 mg/kg PO) to reduce seizure recurrence risk. Aggressive cooling measures (tepid sponging) controversial and not routinely recommended; passive cooling only.

• Diagnostic workup during hospitalization: Lumbar puncture per above criteria. Identification and treatment of underlying infection (antibiotics if bacterial source identified).

Long-term prophylactic management

• Simple febrile seizure (standard risk): No long-term antiepileptic medication routinely recommended. Risk of recurrence approximately 30%, with factors favoring higher recurrence: age <12 months, lower seizure temperature, positive family history, first febrile seizure shortly after fever onset. Parental education regarding recognition of seizures and home safety paramount.

• Intermittent benzodiazepine prophylaxis: Diazepam 0.3 mg/kg PO or rectal at fever onset (given when fever >38.5°C) reduces seizure recurrence by 60% but requires vigilant parental monitoring and carries risk of oversedation. Generally reserved for high-anxiety families or frequent recurrences. Lorazepam 0.05 mg/kg given similarly. Side effects (lethargy, behavioral changes) often limit compliance.

• Continuous antiepileptic prophylaxis (rarely indicated): Reserved for multiple recurrent complex seizures, febrile status epilepticus, or significant family history of afebrile epilepsy. Levetiracetam 10-15 mg/kg/day or valproic acid 15-20 mg/kg/day (divided dosing) most effective. Phenobarbital less preferred due to behavioral side effects in children. Phenytoin ineffective for febrile seizure prevention despite efficacy in acute treatment—paradoxical finding supporting temperature-dependent rather than seizure-threshold mechanisms.

• Non-pharmacologic measures: Anticipatory guidance with fever recognition and management instructions. Home safety counseling (seizure precautions, supervised bathing). Reassurance regarding excellent prognosis. Consideration of seizure action plan in high-risk families.

Monitoring and follow-up

• Post-ictal observation for minimum 2-4 hours until fully alert
• Pediatric neurology consultation if febrile status epilepticus, recurrent complex seizures, or abnormal baseline neurologic exam
• School communication regarding seizure history and emergency procedures
• Annual reassessment as age-dependent risk diminishes

During acute event

• Febrile status epilepticus: Continuous seizure activity or repeated seizures without recovery (occurring in 5-10% of febrile seizures). High risk for aspiration, hypoxemia, physical injury. Requires aggressive benzodiazepine use, airway management, consideration of ICU monitoring. Associated with increased risk of subsequent afebrile epilepsy (10-15% lifetime risk vs. 2-3% in simple febrile seizures).

• Aspiration pneumonia: Risk during prolonged seizures or inadequate airway positioning. Managed with antibiotics targeting oral flora if aspiration suspected clinically.

• Accidental trauma: Head injury, dental trauma, tongue/cheek lacerations from falls or environmental objects. Prevention through seizure precautions and supervision.

• Hypoxemia and cardiovascular stress: Transient desaturation during tonic phase managed with oxygen supplementation. Cardiac dysrhythmias rare but monitor in prolonged seizures.

Long-term sequelae

• Febrile seizure recurrence: Occurs in approximately 30-40% of children with first febrile seizure. Highest risk with: age <12 months at first seizure, fever threshold <38.5°C, positive family history, shorter duration of fever before seizure. Recurrence risk decreases with age; minimal recurrence risk after age 5 years.

• Afebrile epilepsy development: Approximately 2-3% of children with simple febrile seizures develop subsequent afebrile seizures (non-febrile epilepsy), compared to general population risk of 0.8%. Risk increases to 10-15% with complex febrile seizures, multiple recurrences, positive family history of afebrile epilepsy, or underlying developmental abnormality. Children with GEFS+ genetic syndromes have higher lifelong seizure risk.

• No cognitive or developmental impairment: Extensive prospective studies confirm febrile seizures do NOT cause intellectual disability, learning disorders, or behavioral problems. Even febrile status epilepticus shows no cognitive sequelae in most cases.

• Mesial temporal sclerosis (rare): Theoretical association between prolonged febrile seizures and hippocampal sclerosis remains unproven; modern imaging studies show minimal risk of structural damage from febrile seizures alone.

Excellent overall prognosis

• Febrile seizures are self-limited phenomena of early childhood with resolution by age 5-6 years in nearly all cases
• Mortality attributable to febrile seizure itself is extraordinarily rare (<1 per 1000 cases) and typically associated with extreme environmental neglect
• Complete neurologic recovery without sequelae in >98% of cases

Recurrence risk stratification

• Low recurrence risk (<20%): First seizure age >18 months, fever >40°C, seizure within 1 hour of fever onset, complex features absent, no family history
• Higher recurrence risk (50-60%): Age <12 months, fever threshold <38.5°C, family history of febrile seizures, seizure after prolonged fever, multiple prior episodes
• Recurrence risk decreases progressively with age; minimal recurrence after 5 years

Long-term seizure prognosis

• Risk of subsequent afebrile epilepsy: 2-3% in simple febrile seizures vs. general population 0.8% (modest absolute increase)
• Complex febrile seizures or multiple episodes associated with 10-15% risk of afebrile epilepsy
• Positive family history of afebrile epilepsy increases risk substantially
• GEFS+ syndrome carriers have high lifetime seizure risk requiring prolonged monitoring and genetic counseling

Socioeconomic impact

• Significant parental anxiety despite benign prognosis
• Unnecessary investigations and hospitalizations common due to parental concern and provider uncertainty
• Educational burden required to allay fears and prevent overtreatment

• Most important fact: Febrile seizures are NOT epilepsy and do NOT cause long-term neurologic damage. This distinction is crucial for counseling families and avoiding unnecessary long-term antiepileptic therapy.

• Board buzzword—"Simple febrile seizure" checklist: Age 6 months to 5 years, fever ≥38.5°C, generalized tonic-clonic seizure <15 minutes, single seizure per febrile illness, no focal features, no CNS infection, normal baseline development.

• Common clinical trap: Ordering EEG, brain MRI, or prolonged prophylactic antiepileptics for simple febrile seizures—all unnecessary and wasteful. Diagnosis is clinical; investigation focuses on identifying underlying infection cause, not seizure workup.

• Meningitis exclusion principle: LP mandatory